Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Recurrent Multiple Myeloma; Refractory Multiple MyelomaLast Updated:January 30, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Recurrent Multiple Myeloma; Refractory Multiple MyelomaLast Updated:January 30, 2024Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:December 21, 2023Recruiting
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:November 10, 2020Completed
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:August 7, 2019Completed
Condition(s):Multiple MyelomaLast Updated:January 26, 2023Not yet recruiting
Condition(s):Carcinoma, Renal CellLast Updated:January 18, 2017Completed
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:November 13, 2020Unknown status
Condition(s):Multiple MyelomaLast Updated:March 8, 2024Not yet recruiting
Condition(s):Relapsed and/or Refractory Multiple MyelomaLast Updated:April 4, 2019Unknown status
Condition(s):Multiple MyelomaLast Updated:November 9, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.